| Date Filed | Type | Description |
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2020 |
4
| Kim Richard J (President US Comm & Strat Mktg) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 223 shares
@ $58.4, valued at
$13k
|
|
| 01/27/2020 |
4
| Kim Richard J (President US Comm & Strat Mktg) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 5,400 shares
@ $0
Granted 8,800 options to buy
@ $99.66, valued at
$877k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2019 |
4
| Kim Richard J (President US Comm & Strat Mktg) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 111 shares
@ $69.71, valued at
$7.7k
|
|
| 07/03/2019 |
4
| Kim Richard J (President US Comm & Strat Mktg) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 268 shares
@ $79.17, valued at
$21.2k
|
|
| 04/16/2019 |
4
| Kim Richard J (President US Comm & Strat Mktg) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 77 shares
@ $95.21, valued at
$7.3k
|
|
| 04/03/2019 |
4
| Kim Richard J (President US Comm & Strat Mktg) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 267 shares
@ $111.5, valued at
$29.8k
|
|
| 01/18/2019 |
4
| Kim Richard J (President US Comm & Strat Mktg) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 4,000 shares
@ $0
Granted 6,400 options to buy
@ $110.8, valued at
$709.1k
|
|
| 01/15/2019 |
4
| Kim Richard J (President US Comm & Strat Mktg) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 77 shares
@ $109.73, valued at
$8.4k
|
|
| 01/03/2019 |
4
| Kim Richard J (President US Comm & Strat Mktg) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 702 shares
@ $100.79, valued at
$70.8k
|
|
| 10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2018 |
4
| Kim Richard J (President US Comm & Strat Mktg) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 84 shares
@ $65.49, valued at
$5.5k
Paid exercise price by delivering 552 shares
@ $58.42, valued at
$32.2k
Paid exercise price by delivering 89 shares
@ $54.95, valued at
$4.9k
Paid exercise price by delivering 1,101 shares
@ $54.21, valued at
$59.7k
Paid exercise price by delivering 144 shares
@ $61.52, valued at
$8.9k
Paid exercise price by delivering 77 shares
@ $73.07, valued at
$5.6k
Paid exercise price by delivering 144 shares
@ $83.91, valued at
$12.1k
Paid exercise price by delivering 77 shares
@ $97.1, valued at
$7.5k
Paid exercise price by delivering 144 shares
@ $126.46, valued at
$18.2k
|
|
| 02/22/2018 |
4
| Kim Richard J (President U.S. Commercial) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Granted 5,800 shares
@ $0
Granted 8,800 options to buy
@ $58.74, valued at
$516.9k
|
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
3
| Kim Richard J (SVP, Commercial US) has filed a Form 3 on INTERCEPT PHARMACEUTICALS INC |